Tori Whitacre Martonicz

The healthcare sector currently faces an unmet need in treating herpesviruses, hepatitis B, and hepatitis D, which could significantly improve patient outcomes. Addressing this involves considering the necessary steps and understanding the challenges pharmaceutical companies encounter as they work towards developing treatments for these conditions.

Hospitals grapple with the costly burden of healthcare-associated infections (HAIs), and artificial intelligence (AI) is emerging as a game-changer in revolutionizing infection prevention strategies.

A senior microbiologist gives audiences of sister brands, Infection Control Today and Contagion, an insight into leishmaniasis, a potentially fatal disease.

Salem Hospital faces a class action lawsuit over potential hepatitis and HIV exposure to hundreds of patients. The lawsuit alleges negligence and emotional distress, with the hospital claiming a minimal infection risk.